| Title |
Issue Date |
Author(s) |
Journal |
Publisher |
| Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence |
2017 |
Cadoni, Cristina; Pisanu, Augusta; Simola, Nicola; Frau, Lucia; Porceddu, PIER FRANCESCA; Corongi...u, Silvia; Dessi', Christian; Sil, Annesha; Plumitallo, Antonio; Wardas, Jadwiga; DI CHIARA, Gaetano |
NEUROPHARMACOLOGY |
|
| Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent |
2016 |
Frau, Lucia; Costa, Giulia; Porceddu, Pier Francesca; Khairnar, Amit; Castelli, Maria Paola; Enna...s, Maria Grazia; Madeddu, Camilla; Wardas, Jadwiga; Morelli, Micaela |
JOURNAL OF NEUROCHEMISTRY |
|
| Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain |
2016 |
Frau, Lucia; Simola, Nicola; Porceddu, PIER FRANCESCA; Morelli, Micaela |
NEUROTOXICOLOGY |
|
| Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease |
2016 |
Baranyi, M; Porceddu, Pf; Goloncser, F; Kulcsar, S; Otrokocsi, L; Kittel, A; Pinna, A; Frau, L; H...uleatt, Pb.; Khoo, Ml; Chai, Cll.; Dunkel, P; Matyus, P; Morelli, M; Sperlagh, B |
MOLECULAR NEURODEGENERATION |
|
| Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions |
2014 |
KHAIRNAR A; FRAU L; PLUMITALLO A; MORELLI M; SIMOLA N |
JOURNAL OF CAFFEINE RESEARCH |
|
| Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists |
2014 |
SIMOLA N; PINNA A; FRAU L; MORELLI M |
|
Springer |
| Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse |
2014 |
SIMOLA N; FRAU L; PLUMITALLO A; MORELLI M |
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY |
|
| Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease |
2013 |
PINNA A; SIMOLA N; FRAU L; MORELLI M |
|
Springer Science |
| MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice |
2013 |
COSTA G; FRAU L; WARDAS J; PINNA A; PLUMITALLO A; MORELLI M |
MOVEMENT DISORDERS |
|
| Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons |
2013 |
FRAU L; MORELLI M; SIMOLA N |
EXPERIMENTAL NEUROLOGY |
|
| Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility |
2013 |
FRAU L; SIMOLA N; PLUMITALLO A; MORELLI M |
JOURNAL OF NEUROCHEMISTRY |
|
| Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs |
2013 |
FRAU L; SIMOLA N; MORELLI M |
JOURNAL OF CAFFEINE RESEARCH |
|
| Role of movement in long-term basal ganglia changes: implications for abnormal motor responses |
2013 |
SIMOLA N; MORELLI M; FRAZZITTA G; FRAU L |
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE |
|
| Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? |
2012 |
MORELLI M; FRAU L; SIMOLA N |
EXPERIMENTAL NEUROLOGY |
|
| Late-onset Parkinsonism in NFκB/c-Rel-deficient mice |
2012 |
Baiguera, C; Alghisi, M; Pinna, A; Bellucci, A; DE LUCA, Ma; Frau, L; Morelli, M; Ingrassia, R; B...enarese, M; Porrini, V; Pellitteri, M; Bertini, G; Fabene, Pf; Sigala, S; Spillantini, Mg; Liou, Hc; Spano, Pf; Pizzi, M |
BRAIN |
|
| Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. |
2011 |
FRAU L; BORSINI F; WARDAS J; KHAIRNAR AS; SCHINTU N; MORELLI M. |
SYNAPSE |
|
| Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. |
2011 |
Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E. |
NEUROSCIENCE |
|
| A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model |
2011 |
CARTA AR; PISANU A; FRAU L; SPIGA S; CARBONI E |
|
International brain resesearch organization |
| Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain |
2011 |
Khairnar A; Frau L; Fenu S; Plumitallo A; Morelli M |
|
|
| Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age |
2011 |
Frau L; Khairnar A; Fenu S; Morelli M |
|
|
University of Cagliari
